Interaction of positive allosteric modulators with human and Drosophila recombinant GABA receptors expressed in Xenopus laevis oocytes

Delia Belelli, Helen Callachan, Claire Hill-Venning, John A. Peters, Jeremy J. Lambert

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

1. A comparative study of the actions of structurally diverse allosteric modulators on mammalian (human α3 β2 γ(2L)) or invertebrate (Drosophila melanogaster Rdl or a splice variant of Rdl) recombinant GABA receptors has been made using the Xenopus laevis oocyte expression system and the two electrode voltage-clamp technique. 2. Oocytes preinjected with the appropriate cRNAs responded to bath applied GABA with a concentration-dependent inward current. EC50 values of 102 ± 18 μM; 152 ± 10 μM and 9.8 ± 1.7 μM were determined for human α3 β1 γ(2L), Rdl splice variant and the Rdl receptors respectively. 3. Pentobarbitone enhanced GABA-evoked currents mediated by either the mammalian or invertebrate receptors. Utilizing the appropriate GABA EC10, the EC50 for potentiation was estimated to be 45 ± 1 μM, 312 ± 8 μM and 837 ± 25 μM for human α3 β1 γ(2L), Rdl splice variant and Rdl receptors respectively. Maximal enhancement (expressed relative to the current induced by the EC10 concentration of GABA where this latter response = 1) at the mammalian receptor (10.2 ± 1 fold) was greater than that at either the Rdl splice variant (5.5 ± 1.3 fold) or Rdl (7.9 ± 0.8 fold) receptors. 4. Pentobarbitone directly activated the human α3 β1 γ(2L) receptor with an EC50 of 1.2 ± 0.03 mM and had a maximal effect amounting to 3.3 ± 0.4 fold of the response evoked by the EC10 concentration of GABA. Currents evoked by pentobarbitone were blocked by 10-30 μM picrotoxin and potentiated by 0.3 μM flunitrazepam. Pentobarbitone did not directly activate the invertebrate GABA receptors. 5. 5α-Pregnan-3α-ol-20-one potentiated GABA-evoked currents mediated by the human α3 β1 γ(2L) receptor with an EC50 of 87 ± 3 nM and a maximal enhancement of 6.7 ± 0.8 fold of that produced by the GABA EC10 concentration. By contrast, relatively high concentrations (3-10 μM) of this steroid had only a modest effect on the Rdl receptor and its splice variant. 6. A small direct effect of 5α-pregnan-3α-ol-20-one (0.3-10 μM) was detected for the human α3 β1 γ(2L) receptor (maximal effect only 0.08 ± 0.01 times that of the GABA EC10). This response was antagonized by 30 μM picrotoxin and enhanced by flunitrazepam (0.3 μM). 5α-Pregnan-3α-ol-20-one did not directly activate the invertebrate GABA receptors. 7. Propofol enhanced GABA-evoked currents mediated by human α3 β1 γ(2L) and Rdl splice variant receptors with EC50 values of 3.5 ± 0.1 μM and 8 ± 0.3 μM respectively. The maximal enhancement was similar at the two receptor types (human 11 ± 1.8 fold; invertebrate 8.8 ± 1.4 fold that of the GABA EC10).

Original languageEnglish
Pages (from-to)563-576
Number of pages14
JournalBritish Journal of Pharmacology
Volume118
Issue number3
DOIs
Publication statusPublished - Jun 1996

Fingerprint

Xenopus laevis
gamma-Aminobutyric Acid
Oocytes
Invertebrates
Pentobarbital
GABA Receptors
Flunitrazepam
Picrotoxin
Drosophila Rdl protein
Complementary RNA
Patch-Clamp Techniques
Propofol
Drosophila melanogaster
Baths
Electrodes
Steroids

Keywords

  • 5α-pregnan-3α-ol-20-one
  • Drosophila recombinant GABA receptor
  • Etomidate
  • Human recombinant GABA(A) receptor
  • Loreclezole
  • Pentobarbitone
  • Propofol
  • δ-hexachlorocyclohexane

Cite this

@article{69867f0861ac4e249baa1eaeb572f945,
title = "Interaction of positive allosteric modulators with human and Drosophila recombinant GABA receptors expressed in Xenopus laevis oocytes",
abstract = "1. A comparative study of the actions of structurally diverse allosteric modulators on mammalian (human α3 β2 γ(2L)) or invertebrate (Drosophila melanogaster Rdl or a splice variant of Rdl) recombinant GABA receptors has been made using the Xenopus laevis oocyte expression system and the two electrode voltage-clamp technique. 2. Oocytes preinjected with the appropriate cRNAs responded to bath applied GABA with a concentration-dependent inward current. EC50 values of 102 ± 18 μM; 152 ± 10 μM and 9.8 ± 1.7 μM were determined for human α3 β1 γ(2L), Rdl splice variant and the Rdl receptors respectively. 3. Pentobarbitone enhanced GABA-evoked currents mediated by either the mammalian or invertebrate receptors. Utilizing the appropriate GABA EC10, the EC50 for potentiation was estimated to be 45 ± 1 μM, 312 ± 8 μM and 837 ± 25 μM for human α3 β1 γ(2L), Rdl splice variant and Rdl receptors respectively. Maximal enhancement (expressed relative to the current induced by the EC10 concentration of GABA where this latter response = 1) at the mammalian receptor (10.2 ± 1 fold) was greater than that at either the Rdl splice variant (5.5 ± 1.3 fold) or Rdl (7.9 ± 0.8 fold) receptors. 4. Pentobarbitone directly activated the human α3 β1 γ(2L) receptor with an EC50 of 1.2 ± 0.03 mM and had a maximal effect amounting to 3.3 ± 0.4 fold of the response evoked by the EC10 concentration of GABA. Currents evoked by pentobarbitone were blocked by 10-30 μM picrotoxin and potentiated by 0.3 μM flunitrazepam. Pentobarbitone did not directly activate the invertebrate GABA receptors. 5. 5α-Pregnan-3α-ol-20-one potentiated GABA-evoked currents mediated by the human α3 β1 γ(2L) receptor with an EC50 of 87 ± 3 nM and a maximal enhancement of 6.7 ± 0.8 fold of that produced by the GABA EC10 concentration. By contrast, relatively high concentrations (3-10 μM) of this steroid had only a modest effect on the Rdl receptor and its splice variant. 6. A small direct effect of 5α-pregnan-3α-ol-20-one (0.3-10 μM) was detected for the human α3 β1 γ(2L) receptor (maximal effect only 0.08 ± 0.01 times that of the GABA EC10). This response was antagonized by 30 μM picrotoxin and enhanced by flunitrazepam (0.3 μM). 5α-Pregnan-3α-ol-20-one did not directly activate the invertebrate GABA receptors. 7. Propofol enhanced GABA-evoked currents mediated by human α3 β1 γ(2L) and Rdl splice variant receptors with EC50 values of 3.5 ± 0.1 μM and 8 ± 0.3 μM respectively. The maximal enhancement was similar at the two receptor types (human 11 ± 1.8 fold; invertebrate 8.8 ± 1.4 fold that of the GABA EC10).",
keywords = "5α-pregnan-3α-ol-20-one, Drosophila recombinant GABA receptor, Etomidate, Human recombinant GABA(A) receptor, Loreclezole, Pentobarbitone, Propofol, δ-hexachlorocyclohexane",
author = "Delia Belelli and Helen Callachan and Claire Hill-Venning and Peters, {John A.} and Lambert, {Jeremy J.}",
year = "1996",
month = "6",
doi = "10.1111/j.1476-5381.1996.tb15439.x",
language = "English",
volume = "118",
pages = "563--576",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "Wiley",
number = "3",

}

Interaction of positive allosteric modulators with human and Drosophila recombinant GABA receptors expressed in Xenopus laevis oocytes. / Belelli, Delia; Callachan, Helen; Hill-Venning, Claire; Peters, John A.; Lambert, Jeremy J.

In: British Journal of Pharmacology, Vol. 118, No. 3, 06.1996, p. 563-576.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Interaction of positive allosteric modulators with human and Drosophila recombinant GABA receptors expressed in Xenopus laevis oocytes

AU - Belelli, Delia

AU - Callachan, Helen

AU - Hill-Venning, Claire

AU - Peters, John A.

AU - Lambert, Jeremy J.

PY - 1996/6

Y1 - 1996/6

N2 - 1. A comparative study of the actions of structurally diverse allosteric modulators on mammalian (human α3 β2 γ(2L)) or invertebrate (Drosophila melanogaster Rdl or a splice variant of Rdl) recombinant GABA receptors has been made using the Xenopus laevis oocyte expression system and the two electrode voltage-clamp technique. 2. Oocytes preinjected with the appropriate cRNAs responded to bath applied GABA with a concentration-dependent inward current. EC50 values of 102 ± 18 μM; 152 ± 10 μM and 9.8 ± 1.7 μM were determined for human α3 β1 γ(2L), Rdl splice variant and the Rdl receptors respectively. 3. Pentobarbitone enhanced GABA-evoked currents mediated by either the mammalian or invertebrate receptors. Utilizing the appropriate GABA EC10, the EC50 for potentiation was estimated to be 45 ± 1 μM, 312 ± 8 μM and 837 ± 25 μM for human α3 β1 γ(2L), Rdl splice variant and Rdl receptors respectively. Maximal enhancement (expressed relative to the current induced by the EC10 concentration of GABA where this latter response = 1) at the mammalian receptor (10.2 ± 1 fold) was greater than that at either the Rdl splice variant (5.5 ± 1.3 fold) or Rdl (7.9 ± 0.8 fold) receptors. 4. Pentobarbitone directly activated the human α3 β1 γ(2L) receptor with an EC50 of 1.2 ± 0.03 mM and had a maximal effect amounting to 3.3 ± 0.4 fold of the response evoked by the EC10 concentration of GABA. Currents evoked by pentobarbitone were blocked by 10-30 μM picrotoxin and potentiated by 0.3 μM flunitrazepam. Pentobarbitone did not directly activate the invertebrate GABA receptors. 5. 5α-Pregnan-3α-ol-20-one potentiated GABA-evoked currents mediated by the human α3 β1 γ(2L) receptor with an EC50 of 87 ± 3 nM and a maximal enhancement of 6.7 ± 0.8 fold of that produced by the GABA EC10 concentration. By contrast, relatively high concentrations (3-10 μM) of this steroid had only a modest effect on the Rdl receptor and its splice variant. 6. A small direct effect of 5α-pregnan-3α-ol-20-one (0.3-10 μM) was detected for the human α3 β1 γ(2L) receptor (maximal effect only 0.08 ± 0.01 times that of the GABA EC10). This response was antagonized by 30 μM picrotoxin and enhanced by flunitrazepam (0.3 μM). 5α-Pregnan-3α-ol-20-one did not directly activate the invertebrate GABA receptors. 7. Propofol enhanced GABA-evoked currents mediated by human α3 β1 γ(2L) and Rdl splice variant receptors with EC50 values of 3.5 ± 0.1 μM and 8 ± 0.3 μM respectively. The maximal enhancement was similar at the two receptor types (human 11 ± 1.8 fold; invertebrate 8.8 ± 1.4 fold that of the GABA EC10).

AB - 1. A comparative study of the actions of structurally diverse allosteric modulators on mammalian (human α3 β2 γ(2L)) or invertebrate (Drosophila melanogaster Rdl or a splice variant of Rdl) recombinant GABA receptors has been made using the Xenopus laevis oocyte expression system and the two electrode voltage-clamp technique. 2. Oocytes preinjected with the appropriate cRNAs responded to bath applied GABA with a concentration-dependent inward current. EC50 values of 102 ± 18 μM; 152 ± 10 μM and 9.8 ± 1.7 μM were determined for human α3 β1 γ(2L), Rdl splice variant and the Rdl receptors respectively. 3. Pentobarbitone enhanced GABA-evoked currents mediated by either the mammalian or invertebrate receptors. Utilizing the appropriate GABA EC10, the EC50 for potentiation was estimated to be 45 ± 1 μM, 312 ± 8 μM and 837 ± 25 μM for human α3 β1 γ(2L), Rdl splice variant and Rdl receptors respectively. Maximal enhancement (expressed relative to the current induced by the EC10 concentration of GABA where this latter response = 1) at the mammalian receptor (10.2 ± 1 fold) was greater than that at either the Rdl splice variant (5.5 ± 1.3 fold) or Rdl (7.9 ± 0.8 fold) receptors. 4. Pentobarbitone directly activated the human α3 β1 γ(2L) receptor with an EC50 of 1.2 ± 0.03 mM and had a maximal effect amounting to 3.3 ± 0.4 fold of the response evoked by the EC10 concentration of GABA. Currents evoked by pentobarbitone were blocked by 10-30 μM picrotoxin and potentiated by 0.3 μM flunitrazepam. Pentobarbitone did not directly activate the invertebrate GABA receptors. 5. 5α-Pregnan-3α-ol-20-one potentiated GABA-evoked currents mediated by the human α3 β1 γ(2L) receptor with an EC50 of 87 ± 3 nM and a maximal enhancement of 6.7 ± 0.8 fold of that produced by the GABA EC10 concentration. By contrast, relatively high concentrations (3-10 μM) of this steroid had only a modest effect on the Rdl receptor and its splice variant. 6. A small direct effect of 5α-pregnan-3α-ol-20-one (0.3-10 μM) was detected for the human α3 β1 γ(2L) receptor (maximal effect only 0.08 ± 0.01 times that of the GABA EC10). This response was antagonized by 30 μM picrotoxin and enhanced by flunitrazepam (0.3 μM). 5α-Pregnan-3α-ol-20-one did not directly activate the invertebrate GABA receptors. 7. Propofol enhanced GABA-evoked currents mediated by human α3 β1 γ(2L) and Rdl splice variant receptors with EC50 values of 3.5 ± 0.1 μM and 8 ± 0.3 μM respectively. The maximal enhancement was similar at the two receptor types (human 11 ± 1.8 fold; invertebrate 8.8 ± 1.4 fold that of the GABA EC10).

KW - 5α-pregnan-3α-ol-20-one

KW - Drosophila recombinant GABA receptor

KW - Etomidate

KW - Human recombinant GABA(A) receptor

KW - Loreclezole

KW - Pentobarbitone

KW - Propofol

KW - δ-hexachlorocyclohexane

UR - http://www.scopus.com/inward/record.url?scp=0029998302&partnerID=8YFLogxK

U2 - 10.1111/j.1476-5381.1996.tb15439.x

DO - 10.1111/j.1476-5381.1996.tb15439.x

M3 - Article

C2 - 8762079

AN - SCOPUS:0029998302

VL - 118

SP - 563

EP - 576

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 3

ER -